A single intravenous dose of reserpine (0.5 mg/kg) lowers the level of pituitary prolactin and induces lactation in ovariectomized, oestrogen\x=req-\ primed rabbits. These effects can also be produced by placing a discrete electrolytic lesion in the basal tuberal hypothalamus, and following such a lesion, reserpine exerts no further effects on pituitary prolactin or mammary gland activation. In contrast, when reserpine is administered to rabbits bearing lesions elsewhere in the hypothalamus, depletion of pituitary prolactin and lactation ensues. These results suggest that reserpi ne\x=req-\ induced prolactin depletion of the pituitary gland, with subsequent lactation, is mediated by a system within the basal tuberal hypothalamus.
fell to 52 % of the prenursing levels following reserpine treatment. The pos¬ sibility that reserpine may stimulate the release of pituitary lactogenic hor¬ mone via a central nervous control mechanism was suggested by Sawyer (1957) following the observation that a minute amount of reserpine (0.25 mg), too small to evoke the effect when administered systemically, would induce mam¬ mary gland activation when injected into the third cerebral ventricle.
Recently, similar lactational effects have been achieved in oestrogen-primed rabbits by making small electrolytic lesions in the basal tuberai hypothalamus (Hauti 8c Sawyer 1960 . This is the same area in which electrical stimulation induces ovulation . (Kanematsu et al. 1961 ).
MATERIALS AND METHODS
Twenty-nine New Zealand white rabbits (3.6-5.0 kg) were ovariectomized and divided into four groups (Table 1) (Fig. 3 ). Subsequent treatment with reserpine followed the schedule outlined above. As seen in Fig. 1 , reserpine did not significantly change the already-activated condition of the mammary glands (P < 0.2). The terminal pituitary prolactin content was, however, much higher than that of reserpine-treated non-lesioned rabbits (P < 0.001) and not significantly dif¬ ferent from control values (P < 0.3). Desclin (1950) and Everett (1956) 
